4 Stocks Under $2 Insiders Are Aggressively Buying

US gold futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

MSP Recovery

  • The Trade: MSP Recovery, Inc. MSPR Director Thomas W Hawkins acquired a total of 50,000 shares at an average price of $1.08. To acquire these shares, it cost $54.15 thousand.
  • What’s Happening: MSP Recovery recently reaffirmed its sales guidance.
  • What MSP Recovery Does: MSP Recovery Inc is a healthcare recoveries and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services.

Creatd

  • The Trade: Creatd, Inc. CRTD Executive Chairman Jeremy Frommer acquired a total of 1,247 shares at an average price of $0.84. The insider spent around $1.05 thousand to buy those shares.
  • What’s Happening: Creatd recently issued an update on its 2022 slate of three production projects.
  • What Creatd Does: Creatd Inc empowers creators, brands, and entrepreneurs through technology and partnership. The company has three platforms, namely Creatd Labs, Creatd Ventures, and Creatd Partners.

Also check this: Kraft Heinz And 2 Other Stocks Insiders Are Selling

Don’t forget to check out our premarket coverage here .

NanoVibronix

  • The Trade: NanoVibronix, Inc. NAOV Chief Financial Officer Stephen R. Brown acquired a total of 4,000 shares at an average price of $0.57. To acquire these shares, it cost around $2.3 thousand.
  • What’s Happening: NanoVibronix, last month, posted Q1 sales of $272.00K.
  • What NanoVibronix Does: NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals.

Better Therapeutics

  • The Trade: Better Therapeutics, Inc. BTTX Director Geoffrey Parker acquired a total of 25,000 shares at an average price of $1.45. The insider spent $36.18 thousand to buy those shares.
  • What’s Happening: Better Therapeutics recently announced issuance of US patent covering key features of their prescription digital therapeutics platform.
  • What Better Therapeutics Does: Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases.

Posted In: Penny Stocks Insider BuyingLong IdeasNewsPenny StocksInsider TradesMarketsTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.